Bank Of America Corp Mereo Biopharma Group PLC Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Bank Of America Corp holds 2,320 shares of MREO stock, worth $6,797. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,320
Previous 217,557
98.93%
Holding current value
$6,797
Previous $894,000
99.11%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding MREO
# of Institutions
95Shares Held
114MCall Options Held
83.4KPut Options Held
424K-
Janus Henderson Group PLC London, X017.1MShares$50.2 Million0.03% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$44.9 Million0.89% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD9.6MShares$28.1 Million1.34% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.72MShares$25.5 Million0.06% of portfolio
-
Mangrove Partners New York, NY8.64MShares$25.3 Million4.71% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $366M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...